Well, we didn't have to watch Alex Gorsky (photo [1]) for long. According to the Wall Street Journal, when Novartis said that the U.S. pharma CEO was leaving, they left out the part about his returning to alma mater Johnson & Johnson. Gorsky will be chairman of Ethicon, a J&J unit that makes surgical equipment and sutures. Gorsky left J&J to join Novartis in 2004.
Novartis also told the WSJ that Gorsky's exit had nothing to do with any of the changes new worldwide pharma chief Joe Jiminez is making at the company.
- check out the story [2] in the Wall Street Journal
Related Articles:
U.S. CEO exits Novartis. Report [3]
CEO: Novartis plans big restructuring. Report [4]
Lagging sales spur Novartis layoffs. Report [5]
Links:
[1] http://www.fiercebiotech.com/pages/alex-gorsky
[2] http://online.wsj.com/article/SB120300656551568617.html?mod=health_home_stories
[3] http://www.fiercepharma.com/story/u.s.-ceo-exits-novartis/2008-02-14
[4] http://www.fiercepharma.com/story/ceo-novartis-plans-big-restructuring/2007-12-11
[5] http://www.fiercepharma.com/story/lagging-sales-spur-novartis-layoffs/2007-10-18